A phase II study of DuP 937 (Teloxantrone) in metastatic malignant melanoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCICCTG). Academic Article

Overview

authors

Shore, Tsiporah B
Eisenhauer, E
Quirt, I
Belanger, K
Lohmann, R
Silver, H
Wielgosz, G

publication date

September 1, 1993

published in

Annals of oncology : official journal of the European Society for Medical Oncology Journal

Research

keywords

Anthraquinones
Antineoplastic Agents
Melanoma
Pyrazoles

Identity

Scopus Document Identifier

0027442784

PubMed ID

8241003

Additional Document Info

has global citation frequency

6

volume

4

issue

8